Author: IQ TIMES MEDIA

President Donald Trump signed an executive order Thursday evening that directs federal agencies to take aim at state AI laws, arguing startups need relief from a “patchwork” of rules. But legal experts and startups say the order could prolong uncertainty, sparking court battles that leave young companies navigating shifting state requirements while waiting to see if Congress can agree on a single national framework.  The order, titled “Ensuring a National Policy Framework for Artificial Intelligence,” directs the Department of Justice to set up a task force within 30 days to challenge certain state laws on the grounds that AI is…

Read More

Google is rolling out a beta experience that lets you hear real-time translations in your headphones, the company announced on Friday. The tech giant is also bringing advanced Gemini capabilities to Google Translate and expanding its language-learning tools in the Translate app. The new real-time headphone translations experience keeps each speaker’s tone, emphasis, and cadence intact, so it’s easier to follow the conversation and tell who’s saying what, Google says. The new capability essentially turns any pair of headphones into a real-time, one-way translation device. “Whether you’re trying to have a conversation in a different language, listen to a speech…

Read More

ChatGPT, OpenAI’s text-generating AI chatbot, has taken the world by storm since its launch in November 2022. What started as a tool to supercharge productivity through writing essays and code with short text prompts has evolved into a behemoth with 300 million weekly active users. In 2025, OpenAI has battled the perception that it was ceding ground in the AI race to Chinese rivals like DeepSeek, all while the company has tried to shore up its relationship with Washington, pursued ambitious data center projects, and laid the groundwork for one of the largest funding rounds in history. Most recently though,…

Read More

When Scott Hussey heard about the Trump administration’s eagerness to pay for workout equipment in airports, he could not find an upside.If someone got hurt on a pull-up bar, who would they sue? What happens to bags left unattended while travelers get in a few reps? Might this unleash a wave of fitness influencers making – shudder – content at the airport?Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. “It just struck me as being kind of absurd for multiple reasons,” said Hussey, a professional photographer from New Hampshire.At an event…

Read More

PETIT GOÂVE, Haiti (AP) — Amizia Renotte sat on a broken piece of concrete and pointed to a large pile of dirt where her house once stood before the outer bands of Hurricane Melissa crumpled it as the storm lashed Haiti’s southern region.The Atlantic hurricane season may be over, but thousands of people like Renotte in this Carribean country and beyond are still looking for food and struggling to rebuild their lives nearly two months after the Category 5 storm pummeled the northern Caribbean region as one of the strongest Atlantic storms in recorded history.“We ran. We had nothing to…

Read More

Your company’s Dell laptops are about to cost more.Starting December 17, the computer maker is set to hike prices across its commercial product lines, according to an internal list of upcoming price changes sent to staff on December 9 and seen by Business Insider.The list outlines price hikes for Dell’s commercial business — meaning its sales to corporate clients rather than individual consumers. The commercial business accounts for about 85% of Dell’s annual revenue in the Client Solutions Group (CSG), the division that sells laptops and PCs, according to its latest annual results.The company is one of the leading providers…

Read More

PANAMA CITY BEACH, Fla. (AP) — Florida officials are plowing ahead with a proposal to roll back certain vaccine mandates for the state’s schoolchildren, after Republican Gov. Ron DeSantis called for the state to become the first in the nation to eliminate all school vaccination requirements. Pediatricians, infectious disease physicians and teachers have decried the push to undermine vaccines, which for generations have been a cornerstone of public health policy for keeping children and adults safe from potentially deadly — but preventable — diseases. Experts have warned that doing away with the mandates could allow for a dangerous resurgence of…

Read More

Along the 2024 presidential campaign trail, Donald Trump pledged to make in vitro fertilization, or IVF, free – part of his party’s wider push for a new American “baby boom.”But in October 2025, when the administration revealed its IVF proposal, many health care experts pointed out that it falls short of mandating insurance companies to cover the procedure.Since Trump returned to the White House, it has become clear just how fraught IVF is for his base. Some conservative Christians oppose IVF because it often involves destroying extra embryos not implanted in the woman’s uterus.According to Politico, anti-abortion groups lobbied against…

Read More

The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side effects with long-term use, the company said on Thursday.Depression rates in the U.S. have surged 60% over the past decade, affecting more than 20 million adults, according to the Centers for Disease Control and Prevention.Flow’s FL-100 delivers a gentle electrical current to the part of the brain that regulates mood and is designed for home use under remote supervision. It is the first such device to be approved in the U.S.The device is…

Read More

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)Dec 12 (Reuters) – Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive metastatic breast cancer who had responded ​well to initial treatment, according to results of a late-stage trial.Tukysa, known chemically as tucatinib, belongs to a drug class known as ‌tyrosine kinase inhibitors that block the HER2 protein on cancer cells, helping to slow or stop tumor growth.The drug is already approved for use in colorectal cancer and for later-stage breast ‌cancer.The 654 patients in the…

Read More